STAAR Surgical Revenue 2012-2026 | STAA
STAAR Surgical revenue from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
STAAR Surgical Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $239 |
| 2024 | $314 |
| 2023 | $322 |
| 2022 | $284 |
| 2021 | $230 |
| 2020 | $163 |
| 2019 | $150 |
| 2018 | $124 |
| 2017 | $91 |
| 2016 | $82 |
| 2015 | $77 |
| 2014 | $75 |
| 2013 | $72 |
| 2012 | $64 |
| 2011 | $63 |
|
STAAR Surgical Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2026-03-31 | $94 |
| 2025-12-31 | $58 |
| 2025-09-30 | $95 |
| 2025-06-30 | $44 |
| 2025-03-31 | $43 |
| 2024-12-31 | $49 |
| 2024-09-30 | $89 |
| 2024-06-30 | $99 |
| 2024-03-31 | $77 |
| 2023-12-31 | $76 |
| 2023-09-30 | $80 |
| 2023-06-30 | $92 |
| 2023-03-31 | $74 |
| 2022-12-31 | $64 |
| 2022-09-30 | $76 |
| 2022-06-30 | $81 |
| 2022-03-31 | $63 |
| 2021-12-31 | $59 |
| 2021-09-30 | $58 |
| 2021-06-30 | $62 |
| 2021-03-31 | $51 |
| 2020-12-31 | $46 |
| 2020-09-30 | $47 |
| 2020-06-30 | $35 |
| 2020-03-31 | $35 |
| 2019-12-31 | $39 |
| 2019-09-30 | $39 |
| 2019-06-30 | $40 |
| 2019-03-31 | $33 |
| 2018-12-31 | $31 |
| 2018-09-30 | $32 |
| 2018-06-30 | $34 |
| 2018-03-31 | $27 |
| 2017-12-31 | $25 |
| 2017-09-30 | $23 |
| 2017-06-30 | $22 |
| 2017-03-31 | $20 |
| 2016-12-31 | $22 |
| 2016-09-30 | $20 |
| 2016-06-30 | $21 |
| 2016-03-31 | $19 |
| 2015-12-31 | $21 |
| 2015-09-30 | $19 |
| 2015-06-30 | $19 |
| 2015-03-31 | $19 |
| 2014-12-31 | $17 |
| 2014-09-30 | $18 |
| 2014-06-30 | $20 |
| 2014-03-31 | $20 |
| 2013-12-31 | $19 |
| 2013-09-30 | $17 |
| 2013-06-30 | $18 |
| 2013-03-31 | $18 |
| 2012-12-31 | $16 |
| 2012-09-30 | $16 |
| 2012-06-30 | $16 |
| 2012-03-31 | $16 |
| 2011-12-31 | $16 |
| 2011-09-30 | $15 |
| 2011-06-30 | $16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $1.309B | $0.239B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |